Redirecting RNA splicing by SMAD3 turns TGF-β into a tumor promoter
Transforming growth factor β (TGF-β) is a well-known growth inhibitor of normal epithelial cells, but it is also secreted by solid tumors to promote cancer progression. Our recent discovery of SMAD3-PCBP1 complex with direct RNA-binding properties has shed light on how this conversion is implemented...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2017-01-01
|
| Sarja: | Molecular & Cellular Oncology |
| Aiheet: | |
| Linkit: | http://dx.doi.org/10.1080/23723556.2016.1265699 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|